Mean (Standard Deviation) and Adj P-Value | |||||||
---|---|---|---|---|---|---|---|
Absolute Count | Percentage | ||||||
Day | Untreated | TransFix® | Adj P | Untreated | TransFix® | Adj P | |
Total Cell Count | 0 | 71,176.85 (+/− 19,162.46) | – | – | – | – | |
1 | 8944.25 (+/− 7364.30) | 62,898.85 (+/− 15,425.89) | <.0001 | – | – | – | |
2 | 4711.95 (+/− 3629.14) | 74,932.45 (+/− 24,044.26) | <.0001 | – | – | – | |
3 | 2886.10 (+/− 1619.68) | 84,645.90 (+/− 29,320.20) | <.0001 | – | – | – | |
Dead Cells | 0 | 8448.05 (+/− 3559.04) | – | 12.39% (+/− 5.25%) | – | ||
1 | 5939.05 (+/− 3132.97) | – | – | 71.97% (+/− 11.43%) | – | – | |
2 | 3975.25 (+/− 2163.75) | – | – | 89.74% (+/− 9.88%) | – | – | |
3 | 2845.83 (+/− 1504.27) | – | – | 96.80% (+/− 3.29%) | – | – | |
CD3+ Cells | 0 | 687.35 (+/− 577.97) | – | 65.81% (+/− 25.01%) | – | ||
1 | 556.45 (+/ 520.38) | 3058.35 (+/− 2051.57) | <.0001 | 70.63% (+/− 27.07%) | 81.64% (+/− 13.02%) | .4275 | |
2 | 93.7 (+/− 64.21) | 2695.35 (+/− 1808.93) | <.0001 | 75.88% (+/− 20.83%) | 74.28% (+/− 13.65%) | 1.000 | |
3 | 23.63 (+/− 14.94) | 2829.1 (+/− 2267.99) | <.0001 | 92.27% (+/− 10.6%) | 67.81% (+/− 17.56%) | .0456 | |
CD4+ Cells | 0 | 204.85 (+/− 158.67) | – | 21.52% (+/− 9.41%) | – | ||
1 | 242.8 (+/− 249.16) | 1531.0 (+/− 1172.43) | <.0001 | 32.18% (+/− 12.51%) | 41.62% (+/− 12.86%) | <.0001 | |
2 | 41.05 (+/− 48.28) | 1459.25 (+/− 1065.75) | <.0001 | 28.58% (+/− 13.0%) | 40.77% (+/− 12.61%) | <.0001 | |
3 | 6.5 (+/− 3.3) | 1609.15 (+/− 1301.27) | <.0001 | 29.5% (+/− 18.4%) | 40.34% (+/− 11.9%) | .0015 | |
CD11b + Cells (Histogram) | 0 | 1674.25 (+/− 642.09) | – | 93.09% (+/− 2.77%) | – | ||
1 | 443.88 (+/− 308.15) | 25,116.65 (+/− 8471.01) | <.0001 | 86.57% (+/− 5.35%) | 92.36% (+/− 5.0%) | .0417 | |
2 | 276.83 (+/− 257.68) | 26,824.32 (+/− 11,113.98) | <.0001 | 85.3% (+/− 9.85%) | 89.95% (+/− 6.68%) | .2348 | |
3 | 220.0 (+/− 197.99) | 26,962.55 (+/− 8369.15) | <.0001 | 91.58% (+/− 2.38%) | 87.93% (+/− 7.07%) | .9999 | |
CD14+ Cells | 0 | 1706.45 (+/− 3184.47) | – | 46.43% (+/− 17.53%) | – | ||
1 | 93.17 (+/− 143.77) | – | – | 27.69% (+/− 19.08%) | – | – | |
2 | – | – | – | – | – | – | |
3 | – | – | – | – | – | – | |
CD21+ Cells | 0 | 605.45 (+/− 420.98) | – | 22.4% (+/− 15.0%) | – | ||
1 | 156.9 (+/− 163.05) | 742.5 (+/− 919.02) | .0001 | 15.33% (+/− 9.53%) | 16.57% (+/− 13.67%) | 1.000 | |
2 | 15.95 (+/− 15.15) | 415.85 (+/− 304.61) | .0196 | 10.21% (+/− 6.16%) | 10.85% (+/− 7.06%) | 1.000 | |
3 | 2.67 (+/− 2.94) | 308.95 (+/− 289.98) | .5413 | 5.79% (+/− 5.46%) | 7.4% (+/− 7.087%) | .8135 | |
CD45+ Lymphocytes | 0 | 997.2 (+/− 695.28) | – | 99.42% (+/− 0.85%) | – | ||
1 | 720.5 (+/− 543.46) | 3685.85 (+/− 2312.73) | <.0001 | 99.78% (+/− 0.55%) | 99.65% (+/− 0.38%) | .9999 | |
2 | 132.0 (+/− 99.21) | 3503.9 (+/− 2003.84) | <.0001 | 98.81% (+/− 2.16%) | 99.51% (+/− 0.46%) | .2478 | |
3 | 28.14 (+/− 19.57) | 3898.60 (+/− 2636.39) | <.0001 | 99.76% (+/− 0.64%) | 99.41% (+/− 0.61%) | .9962 | |
CD45+ Granulocytes | 0 | 1735.70 (+/− 675.16) | – | 96.63% (+/− 2.16%) | – | ||
1 | 457.27 (+/− 403.02) | 27,341.0 (+/− 9567.06) | <.0001 | 84.38% (+/− 10.96%) | 99.64% (+/− 0.26%) | <.0001 | |
2 | 415.33 (+/− 330.73) | 29,552.29 (+/− 12,476.98) | <.0001 | 94.04% (+/− 1.87%) | 99.64% (+/− 0.23%) | .2415 | |
3 | 322.0 (1 sample) | 30,340.79 (+/− 9239.22) | <.0001 | 83.42% (1 sample) | 99.5% (+/− 0.37%) | .0135 |